MN-001

· MediciNova, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MN-001, covering 2012-01-19 to 2026-02-05. Get the full timeline:

Most recent: Clinical Trial Update: MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and Hypertriglyceridemia [Phase 2]